Pops! Diabetes Care announced today the commercial launch of its blood glucose monitoring system.
The Minneapolis-based company’s device won FDA clearance in December last year.
Get the full story at our sister site, Drug Delivery Business News.
Home » Pops! Diabetes Care launches blood glucose monitoring system
In case you missed it
- Danaher dental spinout Envista prices $589m IPO
- Biotronik first to land MDR certification for a high-risk device
- What cybersecurity compliance support should look like for medical device developers
- Siemens Healthineers wins FDA nod for Artis Icono angiography line
- FDA OKS Avita Medical trial for Recell in soft tissue reconstruction
- Foldax touts FIH procedure for Tria polymer heart valve
- The 20 largest medical device companies in the world
- Abbott wins CE Mark for pediatric heart devices
- Zimmer Biomet warns on Rosa Brain robot software issue
- Orchestra BioMed wins breakthrough nod for Virtue SEB
- KFx defeats Stryker challenge to shoulder anchor patent
- Medtronic launches Envision Pro CGM in Europe
- Medtronic sets robot-assisted surgery platform unveiling
- Bayer leads One Drop’s $40m Series B, inks deal to expand past diabetes
- Biotronik taps Proximo Medical for U.S. peripheral debut
- Saudi Arabia regulators plan new MDMA fees, risk classification system for medical device registrants
- CMR Surgical drums up another $243 million for Versius robotic surgery device
MassDevice Network
@MassDevice
LinkedIn
YouTube
Leave a Reply
You must be logged in to post a comment.